ketoconazole has been researched along with osilodrostat in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Hartmann, RW; Hu, Q; Yin, L | 1 |
| Grombein, CM; Hartmann, RW; Hu, Q; Rau, S; Zimmer, C | 1 |
| Barahona Constanzo, MJ; del Pozo Picó, C | 1 |
| Daniel, E; Newell-Price, JD | 1 |
| Creemers, SG; de Jong, FH; de Rijke, YB; Feelders, RA; Franssen, GJH; Hofland, LJ; van Koetsveld, PM | 1 |
| Tritos, NA | 1 |
| Castinetti, F; Newell-Price, J; Nieman, LK; Reincke, M | 1 |
| Fleseriu, M; Han, AJ; Varlamov, EV | 1 |
4 review(s) available for ketoconazole and osilodrostat
| Article | Year |
|---|---|
New prospects for drug treatment in Cushing disease.
Topics: Adenoma; Adrenocorticotropic Hormone; Animals; Cabergoline; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Ergolines; Etomidate; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Metyrapone; Mice; Mifepristone; Mitotane; Multicenter Studies as Topic; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; PPAR gamma; Pyridines; Rats; Somatostatin; Therapies, Investigational; Tretinoin | 2012 |
Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing's syndrome.
Topics: Cushing Syndrome; Etomidate; Humans; Imidazoles; Ketoconazole; Metyrapone; Mitotane; Pyridines; Steroid Synthesis Inhibitors | 2015 |
Adrenally Directed Medical Therapies for Cushing Syndrome.
Topics: Adrenal Glands; Cushing Syndrome; Etomidate; Humans; Imidazoles; Ketoconazole; Metyrapone; Mitotane; Molecular Targeted Therapy; Pyridines | 2021 |
Updates in adrenal steroidogenesis inhibitors for Cushing's syndrome - A practical guide.
Topics: Cushing Syndrome; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Etomidate; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Metyrapone; Pituitary ACTH Hypersecretion; Practice Patterns, Physicians'; Pyridines; Steroids | 2021 |
4 other study(ies) available for ketoconazole and osilodrostat
| Article | Year |
|---|---|
Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases.
Topics: Aldosterone; Animals; Benzimidazoles; Cardiovascular Diseases; Cytochrome P-450 CYP11B2; Fadrozole; Humans; Indans; Indoles; Kidney Diseases; Mineralocorticoids; Naphthalenes; Quinolines; Receptors, Mineralocorticoid | 2014 |
Heteroatom insertion into 3,4-dihydro-1H-quinolin-2-ones leads to potent and selective inhibitors of human and rat aldosterone synthase.
Topics: Animals; Cell Line; Cytochrome P-450 CYP11B2; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Molecular Structure; Quinolones; Rats; Steroid 11-beta-Hydroxylase; Structure-Activity Relationship | 2015 |
Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study.
Topics: Aldosterone; Cell Culture Techniques; Cortodoxone; Cushing Syndrome; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Metyrapone; Pyridines; Steroid 11-beta-Hydroxylase | 2019 |
Approach to the Patient Treated with Steroidogenesis Inhibitors.
Topics: Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Enzyme Inhibitors; Female; Humans; Imidazoles; Ketoconazole; Metyrapone; Pyridines | 2021 |